Sangamo Therapeutics
SGMO
#9595
Rank
NZ$0.13 B
Marketcap
NZ$0.32
Share price
-25.45%
Change (1 day)
-76.25%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): NZ-$0.76

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.75. In 2024 the company made an earnings per share (EPS) of NZ-$0.87.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.76-12.02%
2024NZ-$0.87
2022NZ-$2.130.81%
2021NZ-$2.1133.33%
2020NZ-$1.586.9%
2019NZ-$1.4822.54%
2018NZ-$1.211.43%
2017NZ-$1.19-31.37%
2016NZ-$1.7375.86%
2015NZ-$0.9948.72%
2014NZ-$0.66-17.02%
2013NZ-$0.809.3%
2012NZ-$0.73-39.44%
2011NZ-$1.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.94-2,631.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.37-3,356.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$15.02-2,106.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$6.28 738.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.65-1,656.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.43-1,761.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$3.06-509.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$3.10-513.64%๐Ÿ‡บ๐Ÿ‡ธ USA